News

The test will be developed by using Chembio’s patented Dual Path Platform (DPP) technology together with proprietary reagents developed by Cornell University and the Oswaldo Cruz Foundation at

Allscripts has announced that Diagnostic Center of Medicine (DCOM) has selected Allscripts Electronic Health Record (EHR) and Practice Management (PM) for its physicians in three locations. DCOM is

Pintek is an industry veteran with deep and broad experience in the life science industry. He joins Luminex from Roche, where he has held several positions of increasing

Oculus Innovative Sciences (Oculus) has confirmed the effectiveness of Microcyn Technology at inactivating the H1NI Swine Influenza A. A virucidal time-kill suspension test conducted by BioScience Laboratories showed

Watson has announced that its subsidiary, Watson Laboratories, has received FDA approval for its Abbreviated New Drug Application (ANDA). The approval is meant for its levonorgestrel tablets, 0.75

Living Cell Technologies (LCT) has announced that New Zealand Ministery of Health has authorized LCT’ New Zealand phase I/IIa clinical trial of Diabecell, for insulin dependent diabetes. The

DiaGenic has signed an agreement with Merz Pharmaceuticals to gain access to biomarkers for Mild Cognitive Impairment (MCI), increasingly considered a transitional stage to Alzheimer’s disease. The biomarkers

Perrigo’s partner Synthon has filed an ANDA for Levocetirizine solution 2.5mg/5ml, a generic version of Xyzal solution 2.5mg/5ml. Xyzal solution 2.5mg/5ml is meant for the treatment of allergies

Financial Highlights Operating profit increased 17.9% to $13.2 million (2008: $11.2 million) EBITDA increased 13.9% to $15.6 million (2008: $13.7 million) and EBITDA margin increased to 29.7% (2008: